Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00998374 · ClinicalTrials.gov registry record

Comparison Between Pyloric Preserving and Non-Pyloric Preserving Bariatric Surgery With Glucose Challenge

A clinical trial of Obesity and Hypoglycemia, sponsored by Medtronic - MITG.

Completed
Registry status
62
Enrollment target
1
Study location

NCT00998374 is a study of Obesity and Hypoglycemia that has completed, run by Medtronic - MITG. The registered enrollment target is 62 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00998374, a study of Obesity and Hypoglycemia, has completed, sponsored by Medtronic - MITG.

COMPLETED
Registry status
62 participants
Enrollment target
1
Study location

Study Summary

This study will compare glucose and simple carbohydrate sensitivity. The hypothesis is that rapid emptying of high-glycemic index foods after Roux-En-Y gastric bypass (RYGB) causes reactive hypoglycemia. It is believed that the controlled release offered by an intact pylorus will be advantageous for long term results in bariatric surgery. This study can provide a scientific rationale, in a short duration of time, for why pylorus sparing surgery, such as the sleeve gastrectomy or duodenal switch, may offer therapeutic advantages, as compared to non-pyloric sparing surgery, namely the gastric bypass.

Conditions Studied

Study Locations (1)

New York

  • Lenox Hill Hospital 186 E76th Street, 1st Floor - New York

Trial Details

FieldValue
Enrollment Target 62 participants
Start Date 2009-09
Est. Completion 2013-04

Sponsor

Medtronic - MITG

119 total trials

What the Registry Record Tells You About NCT00998374

The ClinicalTrials.gov registry entry for NCT00998374 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (92% lower). The listed sponsor is Medtronic - MITG, which has 119 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 0 interventions.

NCT00998374 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT00998374 about?

NCT00998374 is a clinical study titled "Comparison Between Pyloric Preserving and Non-Pyloric Preserving Bariatric Surgery With Glucose Challenge". This study will compare glucose and simple carbohydrate sensitivity. The hypothesis is that rapid emptying of high-glycemic index foods after Roux-En-Y gastric bypass (RYGB) causes reactive hypoglycemia. It is believed that the controlled release offered by an intact pylorus will be advantageous for...

What is the current status of trial NCT00998374?

This trial is currently completed. The enrollment target is 62 participants. The study started on 2009-09. Estimated completion is 2013-04.

What conditions does trial NCT00998374 study?

This clinical trial studies the following conditions: Obesity, Hypoglycemia.

Who is sponsoring clinical trial NCT00998374?

This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00998374 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.